CNS effects of sumatriptan and rizatriptan.
Silberstein
S D
SD
Diener
H-C
HC
McCarroll
K A
KA
Lines
C R
CR
D000328:Adult; D000339:Affect / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects; D018592:Cross-Over Studies; D004244:Dizziness / Q000139:chemically induced; D004311:Double-Blind Method; D004569:Electroencephalography / Q000187:drug effects; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000008:administration & dosage / Q000502:physiology; D009483:Neuropsychological Tests; D004856:Postural Balance / Q000187:drug effects; D011930:Reaction Time / Q000187:drug effects; D021641:Recognition, Psychology / Q000187:drug effects; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000494:pharmacology*; D018170:Sumatriptan / Q000009:adverse effects / Q000494:pharmacology*; D013693:Temazepam / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D014230:Triazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D014363:Tryptamines
D006993:Hypnotics and Sedatives; D009419:Nerve Tissue Proteins; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C093622:rizatriptan; D018170:Sumatriptan; D013693:Temazepam